Purchase Order 75N93024P00117
Award Date
11/27/23
Potential Completion Date
1/31/24
Potential Value
$13K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Stemcell Technologies Inc.
Ultimate Awardee
Stemcell Tecnologies
PSC Category
6509 - Drugs And Biologicals, Veterinary Use
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Kent, WA 98032, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $24,970.00 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract, which has no set-aside designation, is for the delivery of various cell culture research products, such as cell isolation kits, cell culture media, and automated cell separation instruments, to support biomedical...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $24,350.00 firm-fixed-price purchase order contract to Stemcell Technologies Inc., a foreign-owned, for-profit organization, for the provision of human cell enrichment kits. The contract has a completion date of May 31, 2019 and was awarded on May 15, 2018. This contract is not set aside for any specific business type. Stemcell Technologies Inc. is a...
This is a firm fixed-price purchase order awarded to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services. The contract is for the delivery of specialized cell culture kits, including the STEMDIFF MICROGLIA DIFFERENTIATION KIT, STEMDIFF MICROGLIA MATURATION KIT, and STEMDIFF HEMATOPOETIC...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $10,616.40 purchase order contract to Stemcell Technologies Inc. for cell lines. As the prime contractor, Stemcell Technologies will deliver cell lines to NIH/NIAID under the firm fixed price contract. Performance will take place in Kent, Washington over a one-year period from August 2023 through August 2024. No subcontractors or set aside designations were...
This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Stemcell Technologies Inc. The contract, valued at $13,005.00, is for the provision of INTESTICULT OGM HUMAN (AMBIS #2218293) research materials. Stemcell Technologies Inc., a subsidiary of the Canadian company Stemcell Technologies, is a key supplier of specialized biological materials, laboratory supplies,...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $15,645.00 Firm Fixed Price Purchase Order to Stemcell Technologies Inc., a foreign-owned for-profit organization, for the provision of HUMAN CD8 KITS. This award was not set aside for any specific business category. Stemcell Technologies Inc. is a subsidiary of the Canadian company Stemcell Technologies, which develops cell culture media, cell separation...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $17,450.00 Firm Fixed Price purchase order contract to Stemcell Technologies Inc., a Canadian-owned for-profit organization, for the delivery of HUMAN CD8 KITS. The contract has a completion date of June 22, 2018 and does not have a set-aside designation. Stemcell Technologies Inc. is an active supplier of specialized biological materials, laboratory...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $24,605 firm fixed-price purchase order to Stemcell Technologies Inc., a foreign-owned for-profit organization, for the delivery of Human Cell Enrichment Kits. This contract did not have a set-aside designation. Stemcell Technologies Inc. is a subsidiary of the Canadian company Stemcell Technologies, which develops specialized biological materials,...
Stemcell Technologies Inc. was awarded a firm fixed price purchase order valued at twenty-four thousand eight hundred eighty dollars and sixty-two cents ($24,880.62) by the Department of Health and Human Services' National Institutes of Health National Institute on Aging on September 17, 2019. The award has no set-aside designation. Stemcell Technologies Inc. is a subsidiary of Stemcell Technologies, a Canadian company that develops cell culture media, separation systems, and other life sciences...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services (HHS), awarded a $45,760.35 firm-fixed-price purchase order contract to Stemcell Technologies Inc. on January 31, 2017. The contract is for an "Immunomagnetic Cell Separator" and had a completion date of February 28, 2017. Stemcell Technologies Inc. is a Canadian biotechnology company that specializes in cell culture media, cell separation systems, and...